RICE HALL JAMES & ASSOCIATES, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 244 filers reported holding HAEMONETICS CORP in Q2 2022. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$5,180,680
+19.6%
57,833
+13.7%
0.33%
+33.7%
Q2 2023$4,330,306
-10.9%
50,861
-13.4%
0.25%
-10.9%
Q1 2023$4,858,584
+17.4%
58,714
+11.6%
0.28%
+16.5%
Q4 2022$4,139,035
-32.3%
52,626
-36.3%
0.24%
-33.2%
Q3 2022$6,117,000
+21.4%
82,623
+6.9%
0.36%
+45.5%
Q2 2022$5,040,000
+4.0%
77,326
+0.9%
0.24%
+26.4%
Q1 2022$4,845,000
+57.8%
76,645
+32.4%
0.19%
+77.1%
Q4 2021$3,070,000
+0.6%
57,879
+33.9%
0.11%
-3.5%
Q3 2021$3,052,000
-36.2%
43,232
-63.4%
0.11%
-51.5%
Q1 2017$4,786,000
-8.6%
117,978
-9.4%
0.23%
-11.7%
Q4 2016$5,237,000
+10.8%
130,268
-0.2%
0.26%
+6.9%
Q3 2016$4,728,000
+40.5%
130,571
+12.4%
0.25%
+27.3%
Q2 2016$3,366,000
-15.9%
116,121
+1.4%
0.19%
-16.0%
Q1 2016$4,004,000
+11.6%
114,476
+2.9%
0.23%
+12.7%
Q4 2015$3,588,000
+76.3%
111,280
+76.7%
0.20%
+55.3%
Q3 2015$2,035,000
-84.1%
62,977
-79.2%
0.13%
-85.7%
Q4 2013$12,765,000
+36.1%
302,993
+28.9%
0.92%
+2.3%
Q3 2013$9,377,000
-12.0%
235,120
-8.8%
0.90%
-14.4%
Q2 2013$10,659,000257,7831.05%
Other shareholders
HAEMONETICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders